Hypercholesterolemia
Hypercholesterolemia, also known as high cholesterol, is the presence of elevated levels of cholesterol in the blood, which can lead to fatty plaque buildup in the arteries, restricting blood flow and potentially causing heart attacks. Lifestyle factors such as poor diet and smoking, as well as genetics, significantly influence blood cholesterol levels.
Health Outcomes
- Altered Circulating Metabolic Profile
- Altered Fatty Acid Profile in Offspring
- Altered Fatty Acid Profiles
- Altered Lipid Metabolism
- Altered Metabolic Profile
- Altered Metabolite Profile
- Atherogenic Lipid Profile
- Change in Waist-to-Hip Ratio
- Controlled Serum Cholesterol Levels
- Elevated Fecal Cholesterol Levels
- Elevated Serum Lipoprotein Lipase Levels in Gilts
- Enhanced AMPK Activation
- Enhanced Lipid Metabolism in Adipose Tissue
- Enhanced Metabolic Pathway Function
- Enhanced Reverse Cholesterol Transport
- Extended Lifespan in Caenorhabditis elegans
- Improved ApoB-100/ApoA-1 Ratio
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Biochemical Parameters
- Improved Blood Biochemical Indicators
- Improved Blood Biochemical Parameter
- Improved Blood Biochemistry
- Improved Blood Chemistry
- Improved Blood Clinical Chemistry
- Improved Blood Lipid Profile
- Improved Blood Parameters
- Improved Body Mass Index
- Improved Cardiometabolic Health
- Improved Cardioprotective Activity
- Improved Cardiovascular Disease Marker
- Improved Cholesterol Levels
- Improved Cholesterol Metabolism
- Improved Cholesterol Profile
- Improved Cholesterol Regulation
- Improved FGF21 Sensitivity
- Improved Fatty Acid Profile
- Improved Hepatic Cholesterol Homeostasis
- Improved LDL-C to HDL-C Ratio
- Improved Lipid Levels
- Improved Lipid Metabolism
- Improved Lipid Profile
- Improved Lipid Serum Homeostasis
- Improved Low-Density Lipoprotein Composition
- Improved Metabolic Activity of Bacillus coagulans
- Improved Metabolic Disease Markers
- Improved Metabolic Disorders
- Improved Metabolic Function
- Improved Metabolic Health
- Improved Metabolic Parameters
- Improved Metabolic Profile
- Improved Metabolic Regulation
- Improved Metabolic Syndrome Biomarkers
- Improved Metabolism
- Improved Metabolome Profile
- Improved Nutritional Metabolism
- Improved Plasma Cholesterol Clearance
- Improved Plasma Lipid Levels
- Improved Serum Biochemistry
- Improved Serum Lipids
- Improved Serum Parameters
- Improved Systemic Metabolism
- Improved Total Cholesterol Levels
- Improved Triglyceride Levels
- Improved VLDL Cholesterol
- Improved Weight Management
- Increased AMPK Activation
- Increased Alpha-Tocopherol Level
- Increased Apolipoprotein A-1 Level
- Increased Apolipoprotein A-V Levels
- Increased Cholesterol Excretion
- Increased Conjugated Linoleic Acid Production
- Increased Fecal Cholesterol Levels
- Increased HDL Cholesterol Levels
- Increased High-Density Lipoprotein Cholesterol
- Increased Inhibition of Lipid Oxidation
- Increased LDL Cholesterol Level
- Increased Lipid Oxidation
- Increased Lipolysis Activity
- Increased PPAR-γ Activity
- Increased Plasma Level
- Increased Total Cholesterol Level
- Increased n-3 Polyunsaturated Fatty Acid Levels
- Influence on Metabolic Pathways
- Inhibited Lipid Oxidation
- Maintained High-Density Lipoprotein Levels
- Maintained Metabolic Homeostasis
- Maintained Total Cholesterol Level
- Modified Serum Metabolomic Pathways
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in HDL Cholesterol
- No Change in Lipid Profile
- No Change in Metabolic Health
- No Improvement in Total Cholesterol
- No Reduction in Meat Cholesterol Levels
- No Significant Acute Effect on Calcium Metabolism
- No Significant Change in Total Cholesterol
- Normalization of Blood Biochemical Parameters
- Normalized Lipid Metabolism
- Normalized Serum Lipid Levels
- Prevention of Cardiovascular Diseases
- Reduced Aortic Thickness
- Reduced Apolipoprotein B Levels
- Reduced Apolipoprotein B-100
- Reduced Atherogenic Effect
- Reduced Atherogenic Index
- Reduced Atherosclerosis Risk Factors
- Reduced Blood Lipid Levels
- Reduced Blood Serum Cholesterol
- Reduced Blood Stream Cholesterol
- Reduced Body Fat
- Reduced Campesterol Absorption
- Reduced Cardiovascular Disease
- Reduced Cardiovascular Disease Mortality
- Reduced Cardiovascular Risk
- Reduced Cardiovascular Risk Profile
- Reduced Castelli Risk Index I
- Reduced Cholesterol Metabolism
- Reduced Cholesterol Synthesis
- Reduced Coronary Heart Disease Risk
- Reduced De Novo Lipogenesis
- Reduced Dyslipidemia Parameters
- Reduced Dyslipidemia in Metabolic Syndrome
- Reduced HDL Levels
- Reduced HMG-CoA Reductase Inhibition
- Reduced Harmful Lipid Levels
- Reduced Hyperlipidemia Symptoms
- Reduced Incidence of Cardiovascular Disease
- Reduced Intestinal Cholesterol Absorption
- Reduced Ischemic Heart Disease Mortality
- Reduced LDL Cholesterol
- Reduced LDL Cholesterol Level
- Reduced LDL Level
- Reduced LDL Levels
- Reduced LDL Oxidation
- Reduced Lipid Concentrations
- Reduced Lipid Deposition
- Reduced Lipid Level
- Reduced Lipid Levels
- Reduced Lipid Profiles
- Reduced Lipid Synthesis
- Reduced Low-Density Lipoprotein Cholesterol
- Reduced Low-Density Lipoprotein Level
- Reduced Metabolic Disease Risk
- Reduced Metabolic Disorders Incidence
- Reduced Metabolic Dysregulation
- Reduced Metabolic Function
- Reduced Metabolic Inflammation
- Reduced Non-HDL Cholesterol
- Reduced Non-High-Density Lipoprotein Cholesterol
- Reduced Plant Sterols
- Reduced Plasma Cholesterol Levels
- Reduced Plasma Non-Cholesterol Sterols
- Reduced Risk of Coronary Heart Disease
- Reduced Risk of Diabetes
- Reduced Serum Cholesterol
- Reduced Serum Cholesterol Levels
- Reduced Serum LDL Levels
- Reduced Serum Lipid Levels
- Reduced Serum Total Cholesterol Levels
- Reduced Serum Triacylglycerols
- Reduced Serum Triglycerides
- Reduced Symptoms Associated with High-Fat Diet
- Reduced Total Blood Cholesterol
- Reduced Total Cholesterol
- Reduced Total Cholesterol Levels
- Reduced Total Cholesterol to HDL Cholesterol Ratio
- Reduced Total Lipid Levels
- Reduced Triglycerides
- Reduced VLDL Cholesterol Level
- Reduced Very Low-Density Lipoprotein
- Reduced Very Low-Density Lipoprotein Level
- Reduced Yolk Cholesterol Content
- Regulated Blood Lipid Levels
- Regulated Lipid Metabolism
- Regulated Lipid Metabolism in Epididymal Fat Pads
- Regulated Metabolic Function
- Restored HDL Levels
- Restored Lipid Metabolism
- Stabilized Plasma Cholesterol Levels
- Stabilized Visceral Fat Area
- Stable High-Density Lipoprotein Cholesterol Level
- Stable Plasma Cholesterol Levels
- Unchanged HDL Cholesterol Level
- Unchanged LDL Cholesterol Level
- Unchanged Plasma Lipid Levels